The Pharmacological Landscape for Fatty Change of the Pancreas Maxim S. Petrov Leading Article Open access 04 April 2024 Pages: 375 - 384
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects? Sanne M. BuijsStijn L. W. KoolenAgnes Jager Review Article Open access 14 March 2024 Pages: 385 - 401
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines Congrui ZhuShengmei PangQiangde Duan Review Article 23 April 2024 Pages: 403 - 423
Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials Yifan WangHe YiLing Li Systematic Review 13 March 2024 Pages: 425 - 439
Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease Amy Zhuang-YanYahiya Y. Syed Adis Drug Evaluation 30 March 2024 Pages: 441 - 448
Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain Hannah A. Blair Adis Drug Evaluation Open access 09 April 2024 Pages: 449 - 457
Eplontersen: First Approval Tina Nie AdisInsight Report Open access 28 February 2024 Pages: 473 - 478
Fidanacogene Elaparvovec: First Approval Sohita Dhillon AdisInsight Report 12 March 2024 Pages: 479 - 486
Correction: Eplontersen: First Approval Tina Nie Correction Open access 28 March 2024 Pages: 489 - 489